Exagen Inc.

XGN · NasdaqGM

Price$0.00+0.00 (+0.00%)

Price History

Volume & Moving Averages

Price50D200D

Analyst Price Target

$0.00▲ 0.0% above current price

Range: $0.00 – $0.00 · 0 analysts

Based on Wall Street analyst estimates — not a Stockinder prediction.

About the company

Jarvis is thinking

Key Metrics

Report card

Open as standalone page ↗

Jarvis is thinking

Recent Notable Coverage

Jarvis is thinking

Report Card

Growth

Health

Risk

–

Value

Quality

Ownership

Insider and institutional holdings, from Yahoo Finance — for Indian companies this roughly tracks promoter (insiders) and combined FII/DII (institutions) stakes, though not split out the same way a shareholding-pattern filing would.

Insiders27.8%

Institutions44.9%

Public / Other

Income Statement

	2025-12-31	2024-12-31	2023-12-31	2021-12-31	2020-12-31	2019-12-31
Total money the company brought in from its core business during the period, before any costs are subtracted.	$66.58M	$55.64M	$52.55M	$48.30M	$41.98M	$40.39M
The direct costs of producing what was sold — raw materials, manufacturing, direct labor.	$27.78M	$22.53M	$23.09M	$20.59M	$16.56M	$18.81M
Revenue left after subtracting the direct cost of producing goods or services — how efficiently the core business converts sales into profit before overhead.	$38.80M	$33.11M	–	–	–	–
Gross profit as a percentage of revenue.	58.3%	59.5%	–	–	–	–
Profit from core operations after subtracting the cost of revenue and operating expenses like R&D and marketing, but before interest and taxes.	-$14.07M	-$13.64M	-$22.84M	-$24.07M	-$15.19M	-$9.30M
Operating income as a percentage of revenue.	-21.1%	-24.5%	-43.5%	-49.8%	-36.2%	-23.0%
The company's bottom-line profit after all expenses, interest, and taxes are subtracted.	-$19.95M	-$15.12M	-$23.69M	-$26.85M	-$16.69M	-$12.04M
Net income divided by the number of shares outstanding — profit attributable to each share.	$0.00	$0.00	$-1.00	$-1.68	$-1.32	$-8.00
Like basic EPS, but accounts for shares that could be created from stock options or convertible securities — a more conservative per-share profit figure.	$0.00	$0.00	$-1.00	$-1.68	–	–

Balance Sheet

	2025-12-31	2024-12-31	2023-12-31	2021-12-31	2020-12-31	2019-12-31
Cash and highly liquid short-term investments the company can access almost immediately.	$32.22M	$22.04M	$36.49M	$99.44M	$57.45M	$72.08M
Everything the company owns that has value — cash, property, inventory, investments, and more.	$58.02M	$44.69M	$56.94M	$123.44M	$78.38M	$88.31M
All of the company's interest-bearing borrowings, short and long term combined.	$22.91M	$20.25M	$19.50M	$27.48M	$26.66M	$25.85M
Everything the company owes — debt, unpaid bills, and other obligations.	$40.57M	$35.15M	$34.25M	$38.51M	$36.54M	$32.65M
What would be left for shareholders if the company sold all its assets and paid off all its debts — total assets minus total liabilities.	$17.45M	$9.54M	$22.69M	$84.94M	$41.84M	$55.66M

Cash Flow Statement

	2025-12-31	2024-12-31	2023-12-31	2021-12-31	2020-12-31	2019-12-31
Actual cash generated by the core business, as opposed to accounting profit, which can include non-cash items.	-$13.63M	-$13.28M	-$14.46M	-$20.27M	-$14.08M	-$9.71M
Cash spent on physical assets like property, equipment, and infrastructure to maintain or grow the business.	$641000	$515000	$828000	$2.37M	$455000	$403000
Cash left over after capital expenditures — money the company could use for dividends, buybacks, debt repayment, or reinvestment.	-$14.27M	-$13.79M	-$15.29M	-$22.64M	-$14.54M	-$10.11M

	You	Peer avg
Revenue Growth	+15.9%	+2836.6%
ROE	-113.8%	-104.2%

Exagen Inc.

Price History

Volume & Moving Averages

Analyst Price Target

About the company

Key Metrics

Report card

Jarvis Analysis

Recent Notable Coverage

Report Card

Ownership

Quick Actions

Reports & Coverage

Con Call Reports

Board of Directors / Annual Reports

Recent Articles

Income Statement

Balance Sheet

Cash Flow Statement

Peer Comparison